Health Cabinet Secretary Deborah Barasa has reaffirmed Kenya's dedication to providing uninterrupted care for individuals living with HIV, despite recent challenges stemming from a freeze in foreign ...
Arvinas/Pfizer's vepdegestrant shows efficacy in mutated breast cancer patients but not in broader population, failing to ...
Despite government reassurances, health experts have serious concerns about the long-term implications of the withdrawal of ...
The PETITE-DTG study evaluated dolutegravir (DTG) — a drug that revolutionized HIV treatment in adults and children — in ...
Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development at 5 years of age compared with unexposed children, based on new data from ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Arvinas (ARVN), 924% surge in interest Janux Therapeutics ...
A groundbreaking SAMRC study has uncovered significant underreporting of HIV-related deaths in South Africa, despite the ...